Back to Search Start Over

Extracorporeal life support in mitral papillary muscle rupture: Outcome of multicenter study

Authors :
Giulio Massimi
Matteo Matteucci
Michele De Bonis
Mariusz Kowalewski
Francesco Formica
Claudio Francesco Russo
Sandro Sponga
Igor Vendramin
Andrea Colli
Giosuè Falcetta
Cinzia Trumello
Massimiliano Carrozzini
Theodor Fischlein
Giovanni Troise
Guglielmo Actis Dato
Stefano D'Alessandro
Peyman Sardari Nia
Vittoria Lodo
Emmanuel Villa
Shabir Hussain Shah
Roberto Scrofani
Irene Binaco
Jurij Matija Kalisnik
Matteo Pettinari
Matthias Thielmann
Bart Meyns
Fareed A. Khouqeer
Carlo Fino
Caterina Simon
Paolo Severgnini
Adam Kowalowka
Marek A. Deja
Daniele Ronco
Roberto Lorusso
Source :
Artificial Organs.
Publication Year :
2023

Abstract

BACKGROUND: Post-acute myocardial infarction papillary muscle rupture (post-AMI PMR) may present variable clinical scenarios and degree of emergency due to result of cardiogenic shock. Veno-arterial extracorporeal life support (V-A ECLS) has been proposed to improve extremely poor pre- or postoperative conditions. Information in this respect is scarce. METHODS: From the CAUTION (meChanical complicAtion of acUte myocardial infarcTion: an InternatiOnal multiceNter cohort study) database (16 different Centers, data from 2001 to 2018), we extracted adult patients who were surgically treated for post-AMI PMR and underwent pre- or/and postoperative V-A ECLS support. The end-points of this study were in-hospital survival and ECLS complications. RESULTS: From a total of 214 post-AMI PMR patients submitted to surgery, V-A ECLS was instituted in 23 (11%) patients. The median age was 61.7 years (range 46-81 years). Preoperatively, ECLS was commenced in 10 patients (43.5%), whereas intra/postoperative in the remaining 13. The most common V-A ECLS indication was post-cardiotomy shock, followed by preoperative cardiogenic shock and cardiac arrest. The median duration of V-A ECLS was 4 days. V-A ECLS complications occurred in more than half of the patients. Overall, in-hospital mortality was 39.2% (9/23), compared to 22% (42/219) for the non-ECLS group. CONCLUSIONS: In post-AMI PMR patients, V-A ECLS was used in almost 10% of the patients either to promote bridge to surgery or as postoperative support. Further investigations are required to better evaluate a potential for increased use and its effects of V-A ECLS in such a context based on the still high perioperative mortality. ispartof: ARTIFICIAL ORGANS ispartof: location:United States status: Published online

Details

Language :
English
ISSN :
0160564X
Database :
OpenAIRE
Journal :
Artificial Organs
Accession number :
edsair.doi.dedup.....2f14183568273c45eb9f375175ab8cd2